Tagged Articles

malignancies 4 articles

Europe approves new type 2 diabetes drug Invokana

European drug regulators have given the marketing green light to Invokana (canagliflozin), a new type of type 2 diabetes medication. The drug was approved by the U.S. Food and Drug Administration (FDA) in May and was the first in the U.S. and the second in Europe from a new class of medications known as sodium-glucose co-transporter 2 (SGLT2) inhibitors. SGLT2 inhibitors are designed to help reduce blood sugar levels by preventing the reabsorption of glucose from the kidneys back into the blood so that more glucose is excreted in the urine. Invokana is a once-daily treatment for adults with type ... Read More

Chemical in spray tanners may put users at risk for cancer

Spray tans are considered to be a safer way to get the look of a suntan without damaging the skin or risking skin cancer, but a new report suggests the chemicals found in spray tans may be dangerous as well. Six medical experts in the fields of dermatology, toxicology and pulmonary medicine are speaking out about the potential dangers of a chemical commonly found in spray-on tanners – dihydroxyacetone, or DHA. ABC News pulled together the panel of medical experts to review 10 of the most publicly available studies on DHA. While none of the studies were conducted on humans, ... Read More

Research suggests juvenile arthritis drug may not be cause of cancer

University of Alabama Birmingham (UAB) pharmicoepidemiologist Tim Beukelman and his team of researchers combed through millions of records of children to determine if a life-altering drug for juvenile arthritis, called a TNF-Blocker, could cause cancer. The drugs are considered highly effective for the treatment of inflammation attacks on children’s joints as a result of juvenile arthritis, a condition that can be disabling. However, the medication also carries a black box warning that some lymphomas and other malignancies, some of which were fatal, had been reported in children using the drug. Reports of cancer were enough to result in the boxed ... Read More

TNF blockers found to cause cancer in children

The Food and Drug Administration (FDA) announced today that it has completed its analysis on a class of arthritis drugs known as tumor necrosis factor (TNF) blockers and has concluded that there is an increased risk of lymphoma and other cancers associated with use of the drugs. The analysis first came to light in early June through an early communication by the FDA, and early last month the FDA said it would require the drug makers to add a stronger warning to the black box warning currently on the products, which warns of an increased risk of malignancies but does ... Read More